1ST Source Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
23,067
-1,219
-5% -$71.1K 0.07% 118
2025
Q4
$1.31M Sell
24,286
-1,785
-7% -$85.9K 0.07% 119
2025
Q3
$1.18M Sell
26,071
-3,991
-13% -$186K 0.06% 125
2025
Q2
$1.39M Sell
30,062
-20
-0.1% -$982 0.08% 113
2025
Q1
$1.83M Sell
30,082
-497
-2% -$29K 0.11% 96
2024
Q4
$1.73M Buy
30,579
+572
+2% +$32K 0.1% 103
2024
Q3
$1.55M Sell
30,007
-1,746
-5% -$81.9K 0.09% 106
2024
Q2
$1.32M Sell
31,753
-3,575
-10% -$160K 0.08% 114
2024
Q1
$1.92M Sell
35,328
-4,639
-12% -$236K 0.11% 99
2023
Q4
$2.05M Sell
39,967
-1,202
-3% -$63.1K 0.12% 91
2023
Q3
$2.39M Sell
41,169
-131
-0.3% -$8.03K 0.16% 80
2023
Q2
$2.64M Sell
41,300
-1,773
-4% -$119K 0.17% 78
2023
Q1
$2.99M Sell
43,073
-89
-0.2% -$6.28K 0.2% 71
2022
Q4
$3.11M Sell
43,162
-873
-2% -$65.8K 0.2% 68
2022
Q3
$3.13M Sell
44,035
-158
-0.4% -$11.5K 0.23% 58
2022
Q2
$3.4M Sell
44,193
-1,168
-3% -$89K 0.24% 58
2022
Q1
$3.31M Buy
45,361
+256
+0.6% +$17.2K 0.2% 68
2021
Q4
$2.81M Sell
45,105
-92
-0.2% -$5.4K 0.16% 76
2021
Q3
$2.67M Sell
45,197
-197
-0.4% -$13K 0.17% 74
2021
Q2
$3.03M Buy
45,394
+633
+1% +$41.3K 0.19% 69
2021
Q1
$2.83M Sell
44,761
-1,765
-4% -$110K 0.19% 70
2020
Q4
$2.89M Sell
46,526
-12,533
-21% -$771K 0.21% 68
2020
Q3
$3.56M Sell
59,059
-581
-1% -$35K 0.3% 55
2020
Q2
$3.51M Buy
59,640
+1,018
+2% +$60.9K 0.3% 54
2020
Q1
$3.27M Sell
58,622
-605
-1% -$37K 0.33% 51
2019
Q4
$3.8M Buy
59,227
+721
+1% +$41.3K 0.28% 53
2019
Q3
$2.97M Sell
58,506
-6,621
-10% -$311K 0.24% 63
2019
Q2
$2.95M Buy
65,127
+2,587
+4% +$121K 0.24% 63
2019
Q1
$2.98M Sell
62,540
-4,204
-6% -$209K 0.25% 61
2018
Q4
$3.47M Buy
66,744
+375
+0.6% +$20.1K 0.34% 53
2018
Q3
$4.12M Sell
66,369
-150
-0.2% -$8.9K 0.33% 48
2018
Q2
$3.68M Sell
66,519
-4,834
-7% -$261K 0.3% 52
2018
Q1
$4.51M Buy
71,353
+517
+0.7% +$33.3K 0.37% 46
2017
Q4
$4.34M Sell
70,836
-633
-0.9% -$39.6K 0.36% 49
2017
Q3
$4.56M Sell
71,469
-2,765
-4% -$161K 0.38% 48
2017
Q2
$4.14M Buy
74,234
+352
+0.5% +$19.2K 0.36% 49
2017
Q1
$4.02M Buy
73,882
+7,728
+12% +$424K 0.36% 48
2016
Q4
$3.87M Buy
66,154
+1,636
+3% +$89.4K 0.37% 47
2016
Q3
$3.48M Sell
64,518
-1,436
-2% -$92.2K 0.37% 49
2016
Q2
$4.85M Buy
65,954
+37
+0.1% +$2.61K 0.55% 38
2016
Q1
$4.21M Buy
65,917
+1,923
+3% +$121K 0.47% 44
2015
Q4
$4.4M Buy
63,994
+2,456
+4% +$162K 0.51% 43
2015
Q3
$3.64M Buy
61,538
+2,531
+4% +$161K 0.42% 46
2015
Q2
$3.93M Buy
59,007
+2,797
+5% +$184K 0.43% 47
2015
Q1
$3.63M Buy
56,210
+2,082
+4% +$130K 0.43% 51
2014
Q4
$3.19M Buy
54,128
+3,293
+6% +$186K 0.38% 56
2014
Q3
$2.6M Buy
50,835
+1,100
+2% +$54.9K 0.34% 62
2014
Q2
$2.41M Sell
49,735
-1,908
-4% -$94K 0.31% 67
2014
Q1
$2.68M Buy
51,643
+2,500
+5% +$133K 0.36% 55
2013
Q4
$2.61M Sell
49,143
-250
-0.5% -$12.7K 0.35% 59
2013
Q3
$2.29M Buy
49,393
+403
+0.8% +$17.7K 0.34% 64
2013
Q2
$2.19M Buy
+48,990
New +$2.13M 0.37% 60

Other funds holding BMY

1ST Source Bank's BMY Position: Q1 2026 in Review

1ST Source Bank reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q1 2026, selling an estimated $71.1K and leaving 23,067 shares worth $1.4M. The position accounts for 0.07% of the portfolio, ranked #118.

1ST Source Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.85M in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • 1ST Source Bank held 23,067 shares of Bristol-Myers Squibb worth $1.4M as of Q1 2026.
  • 1ST Source Bank sold 1,219 Bristol-Myers Squibb shares in Q1 2026, an estimated $71.1K.
  • Bristol-Myers Squibb made up 0.07% of 1ST Source Bank's portfolio in Q1 2026, its #118 holding.
  • 1ST Source Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 1ST Source Bank's Bristol-Myers Squibb position peaked at $4.85M in Q2 2016.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on 1ST Source Bank's 13F filing for Q1 2026, filed 4 May 2026.